BioCentury
ARTICLE | Clinical News

Enclomiphene citrate regulatory update

November 9, 2015 8:00 AM UTC

FDA cancelled the Nov. 3 meeting of its Bone, Reproductive and Urologic Products Advisory Committee to discuss an NDA from Repros for enclomiphene to treat secondary hypogonadism in overweight men. Re...